{"title":"高阻塞性睡眠呼吸暂停严重程度和缺乏治疗的mashealth有限患者,主要是拉丁裔人群","authors":"Christopher A. Cano , Sogol Javaheri","doi":"10.1016/j.sleep.2025.106648","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>MassHealth Limited (MHL), a subset of Massachusetts’ Medicaid program, covers sleep studies but not obstructive sleep apnea (OSA) treatment, including positive airway pressure (PAP) therapy. This study characterizes the demographics and OSA severity of patients receiving MHL and compares them to those with full MassHealth (MH) benefits to assess inequities in treatment access.</div></div><div><h3>Participants and methods</h3><div>We conducted a retrospective cohort study of 134 MHL and 402 MH patients who underwent a sleep study for OSA evaluation at the Brigham and Women’s Faulkner Hospital (2019–2024). We analyzed age, BMI, OSA severity, SpO<sub>2</sub> % nadir, and comorbidity burden across four patient groups based on insurance and self-reported ethnicity: MHL-Latinx, MH-Latinx, MH-Black, and MH-White, with men and women assessed separately.</div></div><div><h3>Results</h3><div>The MHL population was predominantly Latinx (90 %), with 82 % preferring Spanish, Haitian Creole, or Brazilian Portuguese as their primary language. Moderate-to-severe OSA was most prevalent in MHL-Latinx men (77.5 %) and MHL-Latinx women (53.0 %). On follow-up, about one-third of MHL-Latinx patients with moderate-to-severe OSA obtained PAP therapy through self-pay or insurance change.</div></div><div><h3>Conclusions</h3><div>In this sample of MHL beneficiaries, a predominantly Latinx population, patients experience a high burden of moderate-to-severe OSA yet lack access to PAP therapy due to insurance limitations. Expanding MHL coverage to include OSA treatment is critical to addressing sleep health inequities.</div></div>","PeriodicalId":21874,"journal":{"name":"Sleep medicine","volume":"133 ","pages":"Article 106648"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"High obstructive sleep apnea severity and lack of treatment access in MassHealth Limited patients, a predominantly Latinx population\",\"authors\":\"Christopher A. Cano , Sogol Javaheri\",\"doi\":\"10.1016/j.sleep.2025.106648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>MassHealth Limited (MHL), a subset of Massachusetts’ Medicaid program, covers sleep studies but not obstructive sleep apnea (OSA) treatment, including positive airway pressure (PAP) therapy. This study characterizes the demographics and OSA severity of patients receiving MHL and compares them to those with full MassHealth (MH) benefits to assess inequities in treatment access.</div></div><div><h3>Participants and methods</h3><div>We conducted a retrospective cohort study of 134 MHL and 402 MH patients who underwent a sleep study for OSA evaluation at the Brigham and Women’s Faulkner Hospital (2019–2024). We analyzed age, BMI, OSA severity, SpO<sub>2</sub> % nadir, and comorbidity burden across four patient groups based on insurance and self-reported ethnicity: MHL-Latinx, MH-Latinx, MH-Black, and MH-White, with men and women assessed separately.</div></div><div><h3>Results</h3><div>The MHL population was predominantly Latinx (90 %), with 82 % preferring Spanish, Haitian Creole, or Brazilian Portuguese as their primary language. Moderate-to-severe OSA was most prevalent in MHL-Latinx men (77.5 %) and MHL-Latinx women (53.0 %). On follow-up, about one-third of MHL-Latinx patients with moderate-to-severe OSA obtained PAP therapy through self-pay or insurance change.</div></div><div><h3>Conclusions</h3><div>In this sample of MHL beneficiaries, a predominantly Latinx population, patients experience a high burden of moderate-to-severe OSA yet lack access to PAP therapy due to insurance limitations. Expanding MHL coverage to include OSA treatment is critical to addressing sleep health inequities.</div></div>\",\"PeriodicalId\":21874,\"journal\":{\"name\":\"Sleep medicine\",\"volume\":\"133 \",\"pages\":\"Article 106648\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sleep medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1389945725003235\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1389945725003235","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
High obstructive sleep apnea severity and lack of treatment access in MassHealth Limited patients, a predominantly Latinx population
Objectives
MassHealth Limited (MHL), a subset of Massachusetts’ Medicaid program, covers sleep studies but not obstructive sleep apnea (OSA) treatment, including positive airway pressure (PAP) therapy. This study characterizes the demographics and OSA severity of patients receiving MHL and compares them to those with full MassHealth (MH) benefits to assess inequities in treatment access.
Participants and methods
We conducted a retrospective cohort study of 134 MHL and 402 MH patients who underwent a sleep study for OSA evaluation at the Brigham and Women’s Faulkner Hospital (2019–2024). We analyzed age, BMI, OSA severity, SpO2 % nadir, and comorbidity burden across four patient groups based on insurance and self-reported ethnicity: MHL-Latinx, MH-Latinx, MH-Black, and MH-White, with men and women assessed separately.
Results
The MHL population was predominantly Latinx (90 %), with 82 % preferring Spanish, Haitian Creole, or Brazilian Portuguese as their primary language. Moderate-to-severe OSA was most prevalent in MHL-Latinx men (77.5 %) and MHL-Latinx women (53.0 %). On follow-up, about one-third of MHL-Latinx patients with moderate-to-severe OSA obtained PAP therapy through self-pay or insurance change.
Conclusions
In this sample of MHL beneficiaries, a predominantly Latinx population, patients experience a high burden of moderate-to-severe OSA yet lack access to PAP therapy due to insurance limitations. Expanding MHL coverage to include OSA treatment is critical to addressing sleep health inequities.
期刊介绍:
Sleep Medicine aims to be a journal no one involved in clinical sleep medicine can do without.
A journal primarily focussing on the human aspects of sleep, integrating the various disciplines that are involved in sleep medicine: neurology, clinical neurophysiology, internal medicine (particularly pulmonology and cardiology), psychology, psychiatry, sleep technology, pediatrics, neurosurgery, otorhinolaryngology, and dentistry.
The journal publishes the following types of articles: Reviews (also intended as a way to bridge the gap between basic sleep research and clinical relevance); Original Research Articles; Full-length articles; Brief communications; Controversies; Case reports; Letters to the Editor; Journal search and commentaries; Book reviews; Meeting announcements; Listing of relevant organisations plus web sites.